المؤلفون: Vogelzang, J. L., Stralen, K. J., Noordzij, M., Diez, J. A., Carrero, J. J., Couchoud, C., Dekker, F. W., Finne, P., Fouque, Denis, Heaf, J. G., Hoitsma, A., Leivestad, T., Meester, J., Metcalfe, W., Palsson, R., Postorino, M., Ravani, P., Vanholder, R., Wallner, M., Wanner, C., Groothoff, J. W., Jager, K. J.

المساهمون: Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 0931-0509.

مصطلحات موضوعية: Adolescent, Adult, Female, Humans, Male, Infant, Newborn, Aged, Middle Aged, 80 and over, Risk Factors, Young Adult, Survival Rate, Child, Preschool, Registries, Infection/etiology/*mortality, Kidney Failure, Chronic/*mortality/therapy, Kidney Transplantation/adverse effects, Neoplasms/etiology/*mortality, Renal Dialysis/*adverse effects/*mortality, Renal Replacement Therapy/*adverse effects/*mortality, [SDV]Life Sciences [q-bio]

العلاقة: hal-01850610; https://hal.science/hal-01850610Test

الإتاحة: https://doi.org/10.1093/ndt/gfv007Test
https://hal.science/hal-01850610Test

المؤلفون: W. Mingrone, L. Terraciano, Thomas Ruhstaller, Markus Borner, Dieter Köberle, R. von Moos, Jan C. Schuller, Viviane Hess, Arnaud Roth, Sabine Balmer-Majno, Lucas Widmer, Stephan Bodis, R. A. Popescu, Armin Schnider, B. Pestalozzi

المصدر: Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; Balmermajno, S; Köberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology, 20(9), pp. 1522-8. Oxford: Oxford University Press 10.1093/annonc/mdp045 <http://dx.doi.org/10.1093/annonc/mdp045Test>
Annals of Oncology, Vol. 20, No 9 (2009) pp. 1522-1528

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, Docetaxel, Kaplan-Meier Estimate, Carcinoma/mortality/*therapy, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, medicine, Mucositis, Humans, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Neoadjuvant Therapy, Neoadjuvant therapy, Digestive System Surgical Procedures, Aged, Neoplasm Staging, ddc:616, Taxoids/administration & dosage/adverse effects, Radiotherapy, business.industry, Esophageal disease, Esophageal Neoplasms/mortality/*therapy, Induction chemotherapy, Hematology, Esophageal cancer, Cisplatin/administration & dosage/adverse effects, Middle Aged, medicine.disease, Chemotherapy regimen, Combined Modality Therapy, Surgery, ddc:616.8, Treatment Outcome, Oncology, Taxoids, Female, Cisplatin, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd2ffb79791a1caf26f8554802d9674Test